← Back to headlines
Healthcare Hedge Fund Invests $24.5 Million in Immunovant Stock
A healthcare-focused hedge fund has recently acquired $24.5 million worth of Immunovant stock, prompting investors to consider the potential implications of this significant purchase.
15 Mar, 19:59 — 15 Mar, 19:59
Sources
Showing 1 of 1 sources
Related Stories
Boone Capital Initiates Stake in HealthEquity, Stock Investment Potential Reviewed
34m ago
How to Save Money on Taxes by Following the Rich
49m ago
Top 2 Index Funds to Beat the S&P 500 Over the Next 5 Years, According to Wall Street
59m ago
What Drove Shiba Inu's Double-Digit Move Higher This Past Week?
1h ago